Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial
暂无分享，去创建一个
V. Gebski | N. Pavlakis | V. Ganju | T. Price | N. Tebbutt | K. Sjoquist | J. Shannon | R. Young | A. Veillard | P. Cooray | S. Varma | C. Underhill | D. Ferraro | A. Strickland | N. Wong | M. Hall